A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions

ClinicalTrials.gov ID: NCT02052752

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02052752. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 12, 2026, 8:05 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blinded Study to Evaluate the Ability of an Acne Treatment Product to Produce Visible Improvements in Acne Lesions Over a 5 Day Period of Once-daily Use

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

5 Day study to assess how quickly a topical acne product begins to work.

Study identification

NCT ID: NCT02052752
Recruitment status: Completed
Study type: Interventional
Phase: Phase 4
Lead sponsor: GlaxoSmithKline; Industry
Enrollment: 90 participants

Conditions and interventions

Conditions

Skin Diseases

Interventions

Drug

Eligibility (public fields only)

Age range: 12 Years to 45 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 2014 (Type not available)
Primary completion: May 2014 (Actual)
Completion: May 2014 (Actual)
Last update posted: May 18, 2015

2014

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
GSK Investigational Site	High Point	North Carolina	27262	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02052752, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 18, 2015 · Synced Nov 12, 2026